Titre :

Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU.

Auteur(s) :

Bouadma, Lila [Auteur]
Bouhemad, Belaid [Auteur]
Brissaud, Olivier [Auteur]
Dauger, Stephane [Auteur]
Gibot, Sebastien [Auteur]
Hraiech, Sami [Auteur]
Aix Marseille Université [AMU]
Jung, Boris [Auteur]
Kipnis, Eric [Auteur]
Recherche translationelle relations hôte-pathogènes
Recherche translationnelle : relations hôte-pathogènes - EA 7366
Launey, Yoann [Auteur]
Luyt, Charles-Edouard [Auteur]
Margetis, Dimitri [Auteur]
Michel, Fabrice [Auteur]
Mokart, Djamel [Auteur]
Montravers, Philippe [Auteur]
Monsel, Antoine [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Nseir, Saad [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Pugin, Jerome [Auteur]
Roquilly, Antoine [Auteur]
Velly, Lionel [Auteur]
Zahar, Jean-Ralph [Auteur]
Bruyere, Remi [Auteur]
Chanques, Gerald [Auteur]

Titre de la revue :

Annals of Intensive Care

Nom court de la revue :

Ann. Intensive Care

Numéro :

8

Pagination :

104

Date de publication :

2018-11-03

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

BACKGROUND: The French Society of Anaesthesia and Intensive Care Medicine and the French Society of Intensive Care edited guidelines focused on hospital-acquired pneumonia (HAP) in intensive care unit. The goal of 16 ...
Lire la suite >BACKGROUND: The French Society of Anaesthesia and Intensive Care Medicine and the French Society of Intensive Care edited guidelines focused on hospital-acquired pneumonia (HAP) in intensive care unit. The goal of 16 French-speaking experts was to produce a framework enabling an easier decision-making process for intensivists. RESULTS: The guidelines were related to 3 specific areas related to HAP (prevention, diagnosis and treatment) in 4 identified patient populations (COPD, neutropenia, post-operative and paediatric). The literature analysis and the formulation of the guidelines were conducted according to the Grade of Recommendation Assessment, Development and Evaluation methodology. An extensive literature research over the last 10 years was conducted based on publications indexed in PubMed and Cochrane databases. CONCLUSIONS: HAP should be prevented by a standardised multimodal approach and the use of selective digestive decontamination in units where multidrug-resistant bacteria prevalence was below 20%. Diagnosis relies on clinical assessment and microbiological findings. Monotherapy, in the absence of risk factors for multidrug-resistant bacteria, non-fermenting Gram-negative bacilli and/or increased mortality (septic shock, organ failure), is strongly recommended. After microbiological documentation, it is recommended to reduce the spectrum and to prefer monotherapy for the antibiotic therapy of HAP, including for non-fermenting Gram-negative bacilli.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Inserm
Université de Lille
CHU Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
• Recherche translationnelle : relations hôte-pathogènes - ULR 7366

Équipe(s) de recherche :

Fungal associated invasive and inflammatory diseases

Date de dépôt :

2019-03-01T14:07:53Z
2024-01-29T10:26:56Z